首页|活血化瘀中药防治冠状动脉微循环障碍的分子机制研究进展

活血化瘀中药防治冠状动脉微循环障碍的分子机制研究进展

扫码查看
冠状动脉微循环障碍(CMD)是指冠状动脉微循环结构和功能发生改变,冠状动脉血流量受损,最终导致心肌缺血的临床综合征.临床中中医多以活血化瘀中药治疗CMD.活血化瘀中药可通过多种分子机制对CMD发挥治疗作用,包括改善微血管内皮舒缩功能、促进微血管新生、抑制血管平滑肌细胞异常增殖与迁移、抑制炎症反应、调控心脏细胞的凋亡、抑制氧化应激、改善血小板活化和聚集等.
Research Progress on the Molecular Mechanism of Traditional Chinese Medicine for Promoting Blood Circulation and Removing Blood Stasis for the Prevention and Treatment of Coronary Microvascular Dysfunction
Coronary microvascular dysfunction(CMD)refers to a clinical syndrome characterized by structural and functional alterations in the coronary microcirculation,leading to impaired coronary blood flow(CBF)and ultimately resulting in myocardial ischemia.In clinical practice,traditional Chinese medicine often employs blood-activating and stasis-removing herbs(BAST)to treat CMD.These BAST are believed to exert their therapeutic effects on CMD through various molecular mechanisms,including improving microvascular endothelial relaxation and constriction functions,promoting microvascularneoangiogenesis,inhibiting the abnormal proliferation and migration of vascular smooth muscle cells(VSMCs),suppressing inflammatory responses,regulating apoptosis in cardiac cells,inhibiting oxidative stress,and improving platelet activation and aggregation.

coronary microvascular dysfunctionmolecular mechanismtraditional chinese medicineblood-activating and stasis-removingsignaling pathway

张园园、高媛、赵御凯、董正、陈济川、李岩松、赵智博、司健美、陈会君

展开 >

黑龙江中医药大学,黑龙江 哈尔滨 150040

黑龙江中医药大学附属第二医院,黑龙江 哈尔滨 150040

冠状动脉微循环障碍 分子机制 中药 活血化瘀 信号通路

2024

中医药导报
湖南省中医药学会 湖南省中医管理局

中医药导报

CSTPCD
影响因子:0.952
ISSN:1672-951X
年,卷(期):2024.30(12)